8th Asia Dengue Summit Speakers’ Presentation Video
8th Asia Dengue Summit – Pre-Summit WorkshopOpening Remarks
Dengue Diagnostics in Clinical ManagementReading between the Lines
Lorrie Suzette Urbano-Cruz
Dengue Life Stage Infancy to Adolescent, Adult
LakKumar Fernando
Dengue without warning signs: Outpatient management in the public and private setting
Arthur Dessi Roman
Clinical Management of Dengue with Warning Signs
Ma. Charmian M. Hufano
Severe Dengue Presentations–Pitfalls in the Management
Thea Pamela Cajulao
Severe Dengue & It’s Complications (Sri Lanka Experiences)
LakKumar Fernando
Challenges in Dengue Feverin the Elderly Patient
Jemelyn U. Garcia
Dengue in Special Populations–PREGNANCY
Ricardo Manalastas Jr
Philippine Pediatric Society – Dengue Clinical Management
Florentina U. Ty
Main Summit Day 1
The complex immune drivers of severe dengue disease
Welcome Address Dr. Teodoro J
Keynote Address:Dengue and Global Health
Keynote Manuel M. Dayrit
Building out Aedes mosquitoes: Eliminating dengue as an urban threat
Dr Oliver Brady
Dengue in the Midst of Climate Change The Philippine Experience
Venus Oliva Cloma-Rosales
Dengue epidemiology: modelling for the future
Angkana T. Huang
Dengue pathogenesis:Innate immune reprogramming from prior dengue
Prof. Eng Eong Ooi
Precision in Clinical Practice
Dr. Ramon V. Najarro
From Bedside to Broader Impact
Dr. Arthur Dessi Roman
Dengue Lineage System to Aid Global Surveillance
Nathan Grubaugh
Testing of Dengue
Why don’t we still have atreatment for dengue?
Neelika Malavige
The Current Dengue Therapeutics Guideline and How to Deliver Effective Treatment
André Siqueira
ADVA Educational Symposium Supported by DNDi -Panel Discuss
Dengue human infection models – Filling the immunology knowledge gaps
Adam Waickman
Best Practice in DengueInpatient Management
Janice C. Caoili
Best Practice in Dengue Management:Pediatric & Special Populations
Ramon V. Najarro
Best Practices in DengueClinical Management
Lakkumar Fernando
Dengue immunity in the Philippines: Lessons from the field
Michelle Ylade
Elucidating immune dysregulation in severe dengue
Laura Rivino
Dengue Immunity: Lessons from Clinical Trials
Shirin Kalimuddin
Main Summit Day 2
Key Learnings from theClinical Management Workshop
Lucy Lum Chai See
Key Learnings from the Clinical Management Workshop
Lakkumar Fernando
Mass Vaccination During the 2024 Dengue Outbreak in Brazil
Albert Icksang Ko
Modelling the efficacy and impact of the Takeda dengue vaccine
Ilaria Dorigatti
Dengue Vaccines
Kim Mulholland
Dengue Vaccine In The Private SectorLicensed And Available In Asia: Case Of Thailand
Sunate Chuenkitmongkol
Introducing dengue vaccine in Public the Indonesian experience
William S. Tjeng
Vector control for dengue controlThe current evidence base
Jue Tao Lim
Lessons for integrating innovative vector control tools into dengue control programs
Katie Anders
Human Movement Drives Dengue Transmission
Martin Hibberd
Dengue Slayer Philippines
Dengue Slayer Singapore
Dengue Slayer Malaysia
Dengue Slayer Indonesia
Dengue Slayer Thailand
Dengue advocacy What has been achieved?What still needs to be done?
Marianne Comparet
Philippine Medical Association:“A Pillar of Healthcare Advocacy”
Erica Tania Davillo